CVS up +0.82% percent right now. $CVS High is at 90.18 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
CVS up +0.82% percent right now. $CVS High is at 90.18 and the Low 89.31 with current volume of 1,528,925.

Recent News posted below.

CVS CVS Corp Recent Headline News

Next Resistance Level for CVS Caremark (CVS) is $90.06
Comtex SmarTrend(R) - Tue Nov 11, 9:34AM CST
CVS Caremark (NYSE:CVS) has opened bullishly above the pivot of $88.77 today and has reached the first level of resistance at $89.63. Investors may be interested in a cross of the next upside pivot targets of $90.06 and $91.35.
CVS: 89.63 (+0.44)

3 Stocks Raising The Services Sector Higher
at The Street - Mon Nov 10, 11:08AM CST
TheStreet highlights 3 stocks pushing the health care sector higher today.
CVS: 89.63 (+0.44), WAG: 67.27 (-0.51), UNP: 120.97 (+0.07)

Hess Corporation Tops Best Value Long-Term Bond Ranking
Donald van Deventer - at Seeking Alpha - Sun Nov 09, 8:58AM CST

PSX: 73.56 (-0.94), SCCO: 30.24 (+0.36), SWY: 34.90 (+0.01), HES: 84.14 (+0.33), UTX: 108.21 (-0.79), RTN: 103.55 (+0.03), WMT: 78.99 (-0.45), TAP: 75.98 (-0.67), AMGN: 162.09 (-1.00), COP: 71.68 (+0.08), SWK: 95.90 (+0.02), DO: 36.76 (-0.71), IBM: 163.52 (+0.03), CVS: 89.63 (+0.44), CAT: 102.45 (+0.24), PPG: 205.12 (-1.15), WAG: 67.27 (-0.51)

Is CVS Health's "Tobacco-Tax" Brilliant or Stupid?
Todd Campbell, The Motley Fool - Motley Fool - Sun Nov 09, 8:44AM CST
Source: CVS Health Supporters are heralding CVS Health 's decision to create narrow pharmacy networks that penalize tobacco users as a brilliant move, but detractors think it may alienate customers. Both sides have valid arguments, but I...
ESRX: 77.72 (-0.27), CTRX: 47.90 (-0.12), MCK: 202.43 (+1.15), CVS: 89.63 (+0.44), WAG: 67.27 (-0.51), RAD: 5.49 (+0.03)

Update: CVS Earnings Feel A Cigarette Burn, But How Badly?
The Specialist - at Seeking Alpha - Sun Nov 09, 3:37AM CST

CVS: 89.63 (+0.44), DG: 65.23 (+0.77)

Apple Should Keep Cruising
Orange Peel Investments - at Seeking Alpha - Sat Nov 08, 2:29PM CST

WFM: 47.32 (-0.73), CVS: 89.63 (+0.44), AAPL: 109.23 (+0.40), RAD: 5.49 (+0.03)

3 Things That Can Keep the Wind in Catamaran Corp.'s Sails
Keith Speights, The Motley Fool - Motley Fool - Sat Nov 08, 8:00AM CST
It's been a relatively rough year for Catamaran Corporation so far. Just a couple of weeks ago, the pharmacy benefits manager's stock was down more than 10% and even farther away from the highs seen in 2013. After a strong third-quarter earnings...
CI: 102.15 (+0.87), ESRX: 77.72 (-0.27), CTRX: 47.90 (-0.12), CVS: 89.63 (+0.44)

CVS Caremark Has Returned 12.0% Since SmarTrend Recommendation (CVS)
Comtex SmarTrend(R) - Fri Nov 07, 9:32AM CST
SmarTrend identified an Uptrend for CVS Caremark (NYSE:CVS) on July 24th, 2014 at $78.59. In approximately 4 months, CVS Caremark has returned 11.99% as of today's recent price of $88.01.
CVS: 89.63 (+0.44)

CVS Health Is Poised To Grow
Investing Tricks - at Seeking Alpha - Fri Nov 07, 7:42AM CST

CVS: 89.63 (+0.44)

Discover Financial Services Is Jilted by Apple, but Don't Give Up on Discover Yet
at The Street - Fri Nov 07, 5:10AM CST
Discover isn't part of Apple Pay -- but there just may be a better life outside of Apple's system and in another mobile payments platform.
BCS: 14.93 (+0.06), DFS: 66.39 (+0.05), V: 249.19 (-1.02), AXP: 91.60 (-0.80), WMT: 78.99 (-0.45), CVS: 89.63 (+0.44), BBY: 34.69 (-0.02), AAPL: 109.24 (+0.41), MA: 84.49 (-0.36)

A Gracious Opening For Diplomat Pharmacy Investors
Don Dion - at Seeking Alpha - Thu Nov 06, 3:43PM CST

ESRX: 77.72 (-0.27), DPLO: 21.21 (+0.69), CVS: 89.63 (+0.44), WAG: 67.27 (-0.51)

Apple Pay Will Be a Game Changer But It'll Take Awhile To Get There: Study
at The Street - Thu Nov 06, 9:52AM CST
New research predicts Apple's swipe payment system will be a big success but could take a many years for it to catch on.
AXP: 91.60 (-0.80), WMT: 78.99 (-0.45), M: 58.67 (-0.59), GOOG: 549.05 (+1.56), LUV: 39.40 (+0.28), RAD: 5.49 (+0.03), V: 249.19 (-1.02), EBAY: 54.35 (+0.46), TGT: 65.54 (+0.02), CVS: 89.63 (+0.44), MCD: 95.06 (-0.05), AAPL: 109.24 (+0.41), WAG: 67.27 (-0.51), MA: 84.49 (-0.36)

Did CVS Health Corp. Make the Right Decision When It Stopped Selling Tobacco?
Todd Campbell, The Motley Fool - Motley Fool - Thu Nov 06, 8:39AM CST
Source: CVS Health In order to more closely align the products sold in its stores with its broader mission of improving the health of its customers,   CVS Health    made the bold decision in September to discontinue the sale of tobacco products....
CVS: 89.63 (+0.44), WAG: 67.27 (-0.51), RAD: 5.49 (+0.03)

Update: Apple Gets A Gift From Lawyers, Competitors Face Potential Lawsuit
ColoradoWealthManagementFund - at Seeking Alpha - Thu Nov 06, 8:38AM CST

CVS: 89.63 (+0.44), AAPL: 109.24 (+0.41), RAD: 5.49 (+0.03)

CVS Health Announces Major Expansion of CVS/pharmacy's Annual Free Health Screening Campaign
PR Newswire - Thu Nov 06, 7:39AM CST
CVS Health (NYSE: CVS) today announced the kickoff and major expansion of Project Health, its annual free health screening campaign, at select CVS/pharmacy locations. Over the next four months, the Project Health wellness program will deliver more than $14 million worth of free health services to multicultural communities with a significant number of uninsured or underinsured individuals across the United States. More than 1,000 Project Health events will be held at select CVS/pharmacy stores in 27 markets.
CVS: 89.63 (+0.44)

Monotype Gets Its Font Tech Deeper Into Advertising
at Investor's Business Daily - Wed Nov 05, 5:26PM CST
Monotype Imaging Holdings (TYPE), a leading provider of typefaces and typeface technology, has been on a mission to beauty websites with new and better-rendered fonts. Now the Woburn, Mass.-based company is looking to make digital advertising more...
EBAY: 54.35 (+0.46), PFE: 30.25 (+0.05), CVS: 89.63 (+0.44), COST: 136.73 (-0.96), ADBE: 71.72 (+0.02), TYPE: 28.64 (+0.18)

CVS Caremark Rises 2.38% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Nov 05, 3:56PM CST
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $85.68 to a high of $87.88. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $87.16 on volume of 5.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 89.63 (+0.44)

Pouring A Little Cold Water On Apple Investors
The Financial Lexicon - Seeking Alpha - Wed Nov 05, 1:52PM CST
Apple (NASDAQ: AAPL ) may be the darling of Wall Street, but everything isn't as hunky-dory as Apple's loyal enthusiasts would have you believe. While this may come as a shock to some Apple devotees, Apple does not rule the world. There are...
CVS: 89.63 (+0.44), AAPL: 109.24 (+0.41), RAD: 5.49 (+0.03)

Services Stocks On The Rise With Help From 3 Stocks
at The Street - Wed Nov 05, 11:25AM CST
TheStreet highlights 3 stocks pushing the services sector higher today.
V: 249.19 (-1.02), FOX: 33.39 (+0.10), CVS: 89.63 (+0.44)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 0

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 158

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 328

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 141

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Senator Whitehouse Addresses Challenges in Climate Summit Attendance

Updated Category News Views 330

Senator Whitehouse's Message on Climate Action Sen. Sheldon Whitehouse emphasized a direct message at this year's U.N. climate summit. He assured global negotiators that the United States remains dedicated to climate action, despite the challenges faced during the Trump administration. Challenges at the U.N. Climate Summit Whitehouse specifically pointed out internal...

Continue Reading
The Surge of Spearmint Oil: Insights on Market Growth to 2033

Updated Category News Views 125

Growing Potential of the Spearmint Oil Market Allied Market Research has revealed exciting projections for the spearmint oil market, anticipating it will escalate from a valuation of $180.1 million in recent years to an impressive $377.5 million by 2033, all the while attaining a compound annual growth rate (CAGR) of 7.7% from 2024 to 2033. Factors Fueling Market...

Continue Reading
Exploring Adobe's Stock Growth Track Record Over Two Decades

Updated Category News Views 212

Adobe Stock: A 20-Year Investment Journey Adobe Inc (NASDAQ: ADBE) has demonstrated exceptional stock performance over the past twenty years, consistently outpacing market averages by 5.02% annually. This remarkable growth culminates in an average annual return of 13.66%, showcasing the strength of Adobe’s business model and innovative contributions to the tech...

Continue Reading
Virginia Housing Program Expands Access with New Limits

Updated Category News Views 187

Virginia Housing Introduces New Income and Sales Price Limits Recently, Virginia Housing announced significant updates regarding the maximum gross household income and sales price limits for homebuyers. This change is destined to benefit numerous first-time and repeat homebuyers across the state of Virginia. With these updates, a wider range of individuals and families...

Continue Reading
DraftKings Poised for Strong Growth in Revenue and Earnings

Updated Category News Views 219

Analysts Optimistic About DraftKings' Future Growth DraftKings Inc (NASDAQ: DKNG) is garnering attention as analysts assess the company's outlook for 2025 following its recent fourth-quarter results. Industry experts are weighing in on the potential for substantial growth in revenue and earnings, indicating a positive trajectory for the company. Strong Analyst Ratings...

Continue Reading